This compound is a pharmaceutical intermediate featuring a brominated pyridine ring and a morpholine amide moiety. It is primarily used in the synthesis of drug candidates, particularly those requiring a difluoromethyl ketone functional group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1809323-20-3
Methyl 5-chloro-3,4-dihydroxy-2-methylbenzoate
pharmaceutical intermediate
Methanone, (2-amino-5-chlorophenyl)phenyl-, oxime
pharmaceutical intermediate
5-Chloro-3-nitropyridine-2-carbonitrile
pharmaceutical intermediate
Methyl 2-[(3S)-3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate
pharmaceutical intermediate
2-(5-bromo-2-pyridinyl)-2,2-difluoro-1-morpholin-4-ylethanone
LOZRMBNPPOSKKN-UHFFFAOYSA-N
C1COCCN1C(=O)C(C2=NC=C(C=C2)Br)(F)F
—